Halogen bonding (X-bonding): A biological perspective

被引:364
作者
Scholfield, Matthew R. [1 ]
Vander Zanden, Crystal M. [1 ]
Carter, Megan [1 ]
Ho, P. Shing [1 ]
机构
[1] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA
基金
美国国家科学基金会;
关键词
halogen bond; molecular recognition; protein-inhibitor complexes; drug design; INTERMOLECULAR INTERACTIONS; FORCE-FIELD; BINDING; INHIBITOR; COMPLEXES; GEOMETRY; RECOGNITION; DESIGN; CRYSTALLOGRAPHY; CONFORMATION;
D O I
10.1002/pro.2201
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The concept of the halogen bond (or X-bond) has become recognized as contributing significantly to the specificity in recognition of a large class of halogenated compounds. The interaction is most easily understood as primarily an electrostatically driven molecular interaction, where an electropositive crown, or s-hole, serves as a Lewis acid to attract a variety of electron-rich Lewis bases, in analogous fashion to a classic hydrogen bonding (H-bond) interaction. We present here a broad overview of X-bonds from the perspective of a biologist who may not be familiar with this recently rediscovered class of interactions and, consequently, may be interested in how they can be applied as a highly directional and specific component of the molecular toolbox. This overview includes a discussion for where X-bonds are found in biomolecular structures, and how their structureenergy relationships are studied experimentally and modeled computationally. In total, our understanding of these basic concepts will allow X-bonds to be incorporated into strategies for the rational design of new halogenated inhibitors against biomolecular targets or toward molecular engineering of new biological-based materials.
引用
收藏
页码:139 / 152
页数:14
相关论文
共 77 条
  • [11] Scalable Anisotroplic Shape and Electrostatic Models for Biological Bromine Halogen Bonds
    Carter, Megan
    Rappe, Anthony K.
    Ho, P. Shing
    [J]. JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2012, 8 (07) : 2461 - 2473
  • [12] Assaying the Energies of Biological Halogen Bonds
    Carter, Megan
    Ho, P. Shing
    [J]. CRYSTAL GROWTH & DESIGN, 2011, 11 (11) : 5087 - 5095
  • [13] The Amber biomolecular simulation programs
    Case, DA
    Cheatham, TE
    Darden, T
    Gohlke, H
    Luo, R
    Merz, KM
    Onufriev, A
    Simmerling, C
    Wang, B
    Woods, RJ
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 2005, 26 (16) : 1668 - 1688
  • [14] Clark T, 2007, J MOL MODEL, V13, P291, DOI 10.1007/s00894-006-0130-2
  • [15] Corradi E, 2000, ANGEW CHEM INT EDIT, V39, P1782, DOI 10.1002/(SICI)1521-3773(20000515)39:10<1782::AID-ANIE1782>3.0.CO
  • [16] 2-5
  • [17] The target discovery process
    Egner, U
    Krätzschmar, J
    Kreft, B
    Pohlenz, HD
    Schneider, M
    [J]. CHEMBIOCHEM, 2005, 6 (03) : 468 - 479
  • [18] High resolution crystal structures of piscine transthyretin reveal different binding modes for triiodothyronine and thyroxine
    Eneqvist, T
    Lundberg, E
    Karlsson, A
    Huang, SH
    Santos, CRA
    Power, DM
    Sauer-Eriksson, AE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (25) : 26411 - 26416
  • [19] Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing
    Fedorov, Oleg
    Huber, Kilian
    Eisenreich, Andreas
    Filippakopoulos, Panagis
    King, Oliver
    Bullock, Alex N.
    Szklarczyk, Damian
    Jensen, Lars J.
    Fabbro, Doriano
    Trappe, Joerg
    Rauch, Ursula
    Bracher, Franz
    Knapp, Stefan
    [J]. CHEMISTRY & BIOLOGY, 2011, 18 (01): : 67 - 76
  • [20] Halogen bonding: Recent advances
    Fourmigue, Marc
    [J]. CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE, 2009, 13 (3-4) : 36 - 45